Category: Laser/Light-based DevicesSyndicate content

Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

November 13, 2014 by Brad Perriello

Monteris Medical says it's drummed up a $30 million Series B round for its NeuroBlate laser robotic surgery platform.

Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

Monteris Medical said a pair of new backers joined a $30 million Series B round it plans to use to expand the commercial footprint of its NeuroBlate robotic brain tumor laser.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase lands $35m private placement

November 11, 2014 by Val Kennedy

Dental laser maker Biolase lands a $35 million private placement with a group of investors that includes its chairman, chief executive officer and top stockholders.

Biolase lands $35m private placement

Dental laser maker Biolase (NSDQ:BIOL) said in landed a $35 million private placement with a group of investors that includes its chairman, CEO and top stockholders.

FDA studies show nearly half of LASIK patients report problems

October 21, 2014 by Brad Perriello

Nearly half of the patients who underwent LASIK laser eye surgery reported problems after the procedure, according to an FDA study, although only 1% said the problems interfered with their daily lives.

FDA: Studies show nearly half of LASIK patients report problems

Some 45% of patients who had a laser eye surgery called LASIK later reported at least 1 visual symptom 3 months after the procedure, the FDA said yesterday.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cynosure drops $13.2M on Ellman's RF devices

September 8, 2014 by Arezu Sarvestani

Cynosure rounds out its minimally and non-invasive aesthetics portfolio with the $13.2 million acquisition of Ellman Intl. and its radiofrequency devices.

Cynosure drops $13.2M on Ellman's RF devices

Massachusetts-based Cynosure (NSDQ:CYNO) is looking to expand its market with new radiofrequency-based devices picked up in its $13.2 million acquisition of Ellman Intl.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase ex-CEO demands answers following his board resignation

August 14, 2014 by Arezu Sarvestani

Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.

Biolase ex-CEO demands answers following his resignation

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude and Volcano call a cease-fire

August 8, 2014 by Arezu Sarvestani

St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.

St. Jude and Volcano call a cease-fire

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase ex-CEO Pignatelli ditches the board

August 7, 2014 by Arezu Sarvestani

Biolase's scorned former CEO Federico Pignatelli retires from the board of directors, saying that he was effectively forced out by hostilities from other members.

Biolase ex-CEO Pignatelli steps down from board

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company's board of directors.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp